Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Baliopharm AG
DescriptionBispecific antibody targeting CD 20 and CD 95
Molecular Target CD20 ; Fas receptor (CD95)
Mechanism of ActionBispecific antibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationMultiple sclerosis (MS)
Indication DetailsTreat multiple sclerosis (MS)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today